ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 110,48
-1,04%
Dow Jones
39 806,77
0,00%
DAX
18 679,63
-0,47%
Brent Oil
82,385
-1,37%
Bitcoin
71 319,48
-0,19%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Avant Immunotherapeutics (MM) (AVAN)

  7. Avant Immunotherapeutics (MM) (AVAN) Actualités

AVAN

Avant Immunotherapeutics (MM) (AVAN)

Avant Immunotherapeutics (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AVAN
DateHeureSourceTitreSymboleSociété
29/09/200823h02Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200817h43Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200814h00Business WireAVANT Immunotherapeutics Announces Name Change to Celldex TherapeuticsNASDAQ:AVANAvant Immunotherapeutics (MM)
19/09/200816h28Edgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/09/200822h00Business WireAVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23NASDAQ:AVANAvant Immunotherapeutics (MM)
13/08/200822h53Edgar (US Regulatory)Avant Immunotherapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:AVANAvant Immunotherapeutics (MM)
08/08/200822h16Business WireAVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
06/08/200814h46Business WireCORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
06/08/200814h00Business WireAVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
04/08/200819h56Business WireAVANT to Report Second Quarter 2008 Financial Results on August 6, 2008NASDAQ:AVANAvant Immunotherapeutics (MM)
26/06/200822h47Edgar (US Regulatory)Avant Immunotherapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/06/200817h13Edgar (US Regulatory)Avant Immunotherapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:AVANAvant Immunotherapeutics (MM)
11/06/200814h00Business WireAVANT Announces Vaccine Adjuvant Licenses with 3MNASDAQ:AVANAvant Immunotherapeutics (MM)
04/06/200816h00Business WireAVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
04/06/200813h00Business WireNIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera VaccineNASDAQ:AVANAvant Immunotherapeutics (MM)
03/06/200814h30MarketwiredMarket Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN – NACEL Energy Achieves Objectives With 640 MW Wind Power in DeNASDAQ:AVANAvant Immunotherapeutics (MM)
02/06/200820h32MarketwiredNew Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYONDNASDAQ:AVANAvant Immunotherapeutics (MM)
23/05/200822h04Edgar (US Regulatory)Avant Immunotherapeutics Inc - Amended Current report filing (8-K/A)NASDAQ:AVANAvant Immunotherapeutics (MM)
22/05/200813h00PR Newswire (US)AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual MeetingNASDAQ:AVANAvant Immunotherapeutics (MM)
21/05/200813h00PR Newswire (US)AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to PfizerNYSE:AVAN
19/05/200823h27Edgar (US Regulatory)Avant Immunotherapeutics Inc - Quarterly Report (10-Q)NASDAQ:AVANAvant Immunotherapeutics (MM)
19/05/200823h33Business WireAVANT Reports First Quarter 2008 Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
17/05/200800h16Business WireAVANT Announces Temporary Postponement of Conference CallNASDAQ:AVANAvant Immunotherapeutics (MM)
14/05/200822h00Business WireAVANT to Report First Quarter 2008 Financial Results on May 19, 2008NASDAQ:AVANAvant Immunotherapeutics (MM)
14/05/200814h00Business WireDr. Una Ryan Departs AVANT ImmunotherapeuticsNASDAQ:AVANAvant Immunotherapeutics (MM)
09/05/200816h53Edgar (US Regulatory)Avant Immunotherapeutics Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)NASDAQ:AVANAvant Immunotherapeutics (MM)
16/04/200822h41Business WireAVANT to Host Conference Call Today, April 16, 2008, at 5:00 PM to Discuss CDX-110 Partnership with PfizerNASDAQ:AVANAvant Immunotherapeutics (MM)
16/04/200822h37Business WirePfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain CancerNASDAQ:AVANAvant Immunotherapeutics (MM)
15/04/200822h05Business WireSignificant Tumor-Specific Immune Response Observed in AVANT's Phase 2 Trial Evaluating CDX-110 with Temozolomide for TreatmentNASDAQ:AVANAvant Immunotherapeutics (MM)
04/04/200814h41Business WireFDA Approves ROTARIX(R) Rotavirus VaccineNASDAQ:AVANAvant Immunotherapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:AVAN

Dernières Valeurs Consultées

EU
R156S
R156S
EU
FRSG00014MQ2
SG Issuer Sg Issuer Zc M...
AMEX
BVG
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés